Advisor Group Holdings, Inc. Titan Pharmaceuticals Inc Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.26 - $0.48 $3 - $6	-13 Reduced 26.0%	37 $0
Q3 2023 Nov 13, 2023	BUY	$0.45 - $0.66 $5 - $8	13 Added 35.14%	50 $0
Q4 2022 Feb 10, 2023	BUY	$0.77 - $22.8 $17 - $524	23 Added 164.29%	37 $0
Q1 2022 May 04, 2022	SELL	$0.89 - $1.26 $0 - $1	-1 Reduced 6.67%	14 $0
Q4 2020 Feb 10, 2021	BUY	$3.0 - $6.0 $45 - $90	15 New	15 $0

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $49.4M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.